Head-to-head · Cost-Efficiency Index
REMEVi vs KERNX Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
REMEVi
Cost-first shoppers who want bilingual, LegitScript-certified compounded GLP-1.
Visit REMEViKERNX Health
Shoppers comparing the real cost at their prescribed dose rather than the advertised entry price.
Visit KERNX HealthThe verdict
REMEVi takes it, leading the Cost-Efficiency Index 80 to 79. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated. KERNX Health still earns a C — Shoppers comparing the real cost at their prescribed dose rather than the advertised entry price.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs REMEVi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | REMEVi | KERNX Health |
|---|---|---|
| Cost-Efficiency Index | 80/100 | 79/100 |
| Semaglutide / mo | $219/mo | $129/mo (compounded) |
| Tirzepatide / mo | $319/mo | $229/mo (compounded) |
| Semaglutide / yr (modeled) | $2,628 | $1,548 |
| Tirzepatide / yr (modeled) | $3,828 | $2,748 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #33 | #36 |
REMEVi
80/100Where the value is
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
The tradeoffs
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
KERNX Health
79/100Where the value is
- Names individual licensed providers (MDs and NPs) with credentials rather than a vague 'our doctors' claim
- Serves all 50 states through a licensed physician network
- Publishes the full dose ladder for both molecules — semaglutide to $199, tirzepatide to $329 — so the cost at a higher dose is knowable before starting
The tradeoffs
- A separate one-time consultation fee of $25 to $60 applies on top of the first month's medication cost
- No specific compounding pharmacy partner is named anywhere public
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.